Table 2.
SBP ≥140/90 mm Hg, n = 653 | Taking antihypertensive medication, n = 251 | P value | |
---|---|---|---|
Donation to last follow-up, yr, mean ± SD | 15.4 ± 10.1 | 11.7 ± 9.5 | <0.001 |
Age, yr, median (IQR) | 45 (35–54) | 52 (45–59) | <0.001 |
<35, n (%) | 159 (24.3) | 12 (4.8) | |
35–50, n (%) | 258 (39.5) | 100 (39.8) | |
>50, n (%) | 236 (36.1) | 139 (55.4) | |
Male, n (%) | 342 (52.4) | 109 (43.4) | 0.02 |
Race/ethnicity, n (%) | <0.001 | ||
Non-Hispanic white | 537 (82.2) | 229 (91.2) | |
Non-Hispanic black | 89 (13.6) | 10 (4.0) | |
Hispanic | 10 (1.5) | 1 (0.4) | |
Asian | 5 (0.8) | 3 (1.2) | |
Other | 2 (0.3) | 3 (1.2) | |
Unknown | 10 (1.5) | 5 (2.0) | |
Related to recipient, n (%) | 502 (77.2) | 163 (65.2) | <0.001 |
First-degree relative with hypertension, n (%) | 249 (41.8) | 156 (64.5) | <0.001 |
First-degree relative with diabetes, n (%) | 230 (38.1) | 94 (39.0) | 0.82 |
First-degree relative with kidney disease, n (%) | 408 (65.8) | 146 (59.6) | 0.09 |
First-degree relative with heart disease, n (%) | 210 (35.3) | 125 (52.3) | <0.001 |
College or higher education level, n (%) | 315 (48.2) | 144 (57.4) | 0.01 |
Weight, kg, median (IQR) | 82.0 (72.0–93.8) | 84.6 (73.0–95.7) | 0.11 |
BMI, kg/m2, median (IQR) | 27.7 (24.8–30.8) | 28.9 (26.3–32.3) | <0.001 |
Fasting glucose, mg/dl, median (IQR) | 95 (88–102) | 97 (91–104) | 0.01 |
SBP, mm Hg, median (IQR) | 145 (142–149) | 133 (124–141) | <0.001 |
DBP, mm Hg, median (IQR) | 84 (78–89) | 80 (74–85) | <0.001 |
One artery in nondonated kidney, n (%) | 428 (68) | 163 (66) | 0.62 |
Left kidney removed, n (%) | 473 (73) | 185 (75) | 0.60 |
Creatinine, mg/dl, median (IQR) | 1.0 (0.8–1.1) | 1.0 (0.9–1.1) | 0.44 |
eGFR, ml/min/1.73 m2, median (IQR) | 85 (73–98) | 76 (67–88) | <0.001 |
BMI, body mass index; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; IQR, interquartile range; SBP, systolic blood pressure; SD, standard deviation.